| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |